TMCC1-AS1

Across TCGA pan-cancer cohorts, TMCC1-AS1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated TMCC1-AS1 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher TMCC1-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TMCC1-AS1 expression acts as an unfavorable survival marker, although some lineages such as UCS and LGG show a favorable association.

LIHC, UCS, and LGG are the cancer types where TMCC1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.699	0.849	<.001	103	view →
UCS	DFS	Median	II,III,IV	0.579	0.145	<.001	70	view →
LGG	DFS	Median	All	0.799	0.674	<.001	42	view →
ACC	DFS	Tertile	All	0.207	0.662	.003	31	view →
HNSC	DFS	Tertile	IV	0.718	0.528	.002	29	view →
BRCA	OS	Median	IV	0.859	0.371	.001	21	view →
KIRP	DFS	Quartile	All	0.819	0.958	.001	21	view →
UCEC	OS	Quartile	All	0.825	0.909	.019	20	view →
KIRC	DFS	Quartile	All	0.752	0.884	.015	14	view →
ESCA	DFS	Tertile	All	1.000	0.463	.014	11	view →
MESO	DFS	Tertile	IV	0.309	0.723	.032	9	view →
PCPG	DFS	Quartile	All	1.000	0.671	.023	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

TMCC1-AS1–LIHC (OS)

Open the LIHC breakdown →